You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Regimen
Published Date: 12 May 2025
Cancer Type:
Lung, 
Non-Small Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses, Supplementary Drug Funding and Cycle Frequency sections

May 2025
Regimen
Published Date: 12 May 2025
Cancer Type:
Lung, 
Non-Small Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Rationale/uses, Supplementary public funding, Cycle frequency, and Adverse effects sections

May 2025
Regimen
Published Date: 12 May 2025
Cancer Type:
Lung, 
Non-Small Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Rationale and Uses, Supplementary Drug Funding, and Cycle Frequency sections

May 2025
Regimen
Published Date: 12 May 2025
Cancer Type:
Lung, 
Non-Small Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Rationale and Uses, Supplementary Drug Funding, and Cycle Frequency sections

May 2025
Regimen
Published Date: 12 May 2025
Cancer Type:
Lung, 
Non-Small Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Rationale and Uses, Supplementary Drug Funding, and Cycle Frequency sections

May 2025
Regimen
Published Date: 12 May 2025
Cancer Type:
Lung, 
Non-Small Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Rationale and Uses, Supplementary Drug Funding, and Cycle Frequency sections

May 2025
Regimen
Published Date: 12 May 2025
Cancer Type:
Gynecologic, 
Cervix
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Adverse effects section

May 2025
Regimen
Published Date: 12 May 2025
Cancer Type:
Skin, 
Basal Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Rationale and Uses, Supplementary Public Funding, Cycle Frequency, and Adverse effects sections

May 2025
Drug

Published Date: 12 May 2025

Revision Summary:
Drug Monograph: Updated Adverse effects section
May 2025
Regimen
Published Date: 12 May 2025
Cancer Type:
Skin, 
Squamous Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Adverse effects section

May 2025
Regimen
Published Date: 07 May 2025
Cancer Type:
Lung, 
Non-Small Cell
Intent: Neoadjuvant
Revision Summary:

Regimen Monograph: new ST-QBP regimen

May 2025
Regimen
Published Date: 07 May 2025
Cancer Type:
Hematologic, 
Lymphoma - Hodgkin
Intent: Curative
Revision Summary:

Regimen Monograph: new ST-QBP regimen

May 2025

Pages